Bidding 21-25 May 2026, price band ₹326–343, lot 400 shares.
GMP last updated: 29 May 2026, 9:34 AM IST
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 28 May | ₹112 | ₹455 | 32.65% |
| 27 May | ₹129 | ₹472 | 37.61% |
| 26 May | ₹124 | ₹467 | 36.15% |
| 25 May | ₹108 | ₹451 | 31.49% |
| 24 May | ₹101 | ₹444 | 29.45% |
| 23 May | ₹125 | ₹468 | 36.44% |
| 22 May | ₹127 | ₹470 | 37.03% |
| 21 May | ₹127 | ₹470 | 37.03% |
| 20 May | ₹117 | ₹460 | 34.11% |
| 19 May | ₹141 | ₹484 | 41.11% |
| 18 May | ₹110 | ₹453 | 32.07% |
| 17 May | ₹69 | ₹412 | 20.12% |
| 16 May | ₹0 | ₹343 | 0.00% |
After allotment
| Category | Times | Est. Allotment Chances* |
|---|---|---|
| HNIs (Total) | 145.96🔥 | 0.69% |
| bHNI | 178.29🔥 | 0.56% |
| sHNI | 81.3🔥 | 1.2% |
| QIBs | 123.94🔥 | - |
| Retail | 71.18🔥 | 1.4% |
| Total | 102.28🔥 | - |
*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.
Q-Line Biotech Limited is an in-vitro diagnostics (IVD) company engaged in the manufacturing and trading of biochemistry reagents, diagnostic instruments and consumables used in healthcare testing and laboratory applications. The company operates multiple manufacturing facilities in Uttar Pradesh and Delhi and offers products across categories such as ELISA, molecular diagnostics, chemiluminescence immunoassay (CLIA), immuno fluorescence assay (IFA), nucleic acid extraction kits and PCR-based diagnostic kits. Its product portfolio includes tests for infectious diseases, thyroid disorders, cardiac markers and other clinical conditions. The company generates revenue primarily through the sale of its diagnostic products and instruments, largely through a network of distributors, including group entity POCT Services. Q-Line Biotech also focuses on research and development through its subsidiary, Q-Line Innovations Private Limited, which works on developing diagnostic and scientific equipment and consumables.